Artesunate (Test) + Artesunate (Comparator)
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Falciparum Malaria
Conditions
Falciparum Malaria
Trial Timeline
Jun 1, 2009 → Aug 1, 2009
NCT ID
NCT00894374About Artesunate (Test) + Artesunate (Comparator)
Artesunate (Test) + Artesunate (Comparator) is a phase 1 stage product being developed by Pfizer for Falciparum Malaria. The current trial status is completed. This product is registered under clinical trial identifier NCT00894374. Target conditions include Falciparum Malaria.
What happened to similar drugs?
3 of 5 similar drugs in Falciparum Malaria were approved
Approved (3) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00894374 | Phase 1 | Completed |
Competing Products
20 competing products in Falciparum Malaria